. The underlying mechanisms of uveitis, or intraocular inflammation, remain poorly understood. However, a recently identified gene called NOD2 provides important insight into the genetics involved in the pathogenesis of uveitis. Specific mutations within NOD2 are the cause of an inherited multisystem granulomatous disease affecting the eye, joints and skin that develop in the absence of infection. While pathogenic mutations have been identified, the functions of NOD2 responsible for initiation of ocular inflammation have not. We have succeeded in establishing a model of NOD2-dependent uveitis, wherein NOD2 is activated by its synthetic agonist muramyl dipeptide (MDP). We propose to use this model to investigate the mechanisms by which NOD2 could initiate uveitis either via its direct activation by its agonist (in the absence of infection as might occur in Blau syndrome) or by its ability to regulate inflammation induced by either toll-like receptors (TLRs) or by the homologous family member, NOD1. Specifically, we will 1) Identify which cells respond to MDP and investigate the role of IFNg as a modulator of NOD2-driven ocular inflammation;2) Since our discovery that NOD1 triggers uveitis, we propose to investigate whether NOD1 and NOD2-induced ocular inflammatory response are distinguishable and whether cross-talk occurs;and 3) Since NOD2 appears to exert its most measurable biological effects when it modulates TLRs, we will explore the capacity of NOD2 to regulate TLR responses within the eye.
This aim will also explore how MDP affects the inflammatory response triggered by IL-1b. Together, these studies will have considerable implications for understanding pathological mechanisms involved in uveitis.
PROJECT NARRATIVE/SIGNIFICANCE. """"""""Experiments"""""""" in nature can lead to personal suffering while concomitantly offering unique opportunities to elucidate human biology. This is best exemplified in Blau syndrome, wherein a single base pair change in the NOD2 gene results in complete penetrance for the induction of uveitis and multisystem granulomatous disease. The connection between a single gene and uveitis offers enormous potential to study the pathogenesis of uveitis.
|Lee, Ellen J; Allensworth, Jordan J; Clowers, Jenna S et al. (2015) Aberrant interleukin-1 signalling does not increase susceptibility of mice to NOD2-dependent uveitis. Clin Exp Ophthalmol 43:349-57|
|Clowers, Jenna S; Allensworth, Jordan J; Lee, Ellen J et al. (2013) Investigation of the peptidoglycan sensing molecule, PGLYRP-2, in murine inflammatory uveitis. Br J Ophthalmol 97:504-10|
|Kezic, Jelena M; Glant, Tibor T; Rosenbaum, James T et al. (2012) Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis. Arthritis Res Ther 14:R18|
|Rosenzweig, Holly L; Woods, April; Clowers, Jenna S et al. (2012) The NLRP3 inflammasome is active but not essential in endotoxin-induced uveitis. Inflamm Res 61:225-31|
|Willermain, Francois; Rosenbaum, James T; Bodaghi, Bahram et al. (2012) Interplay between innate and adaptive immunity in the development of non-infectious uveitis. Prog Retin Eye Res 31:182-94|
|Rosenbaum, James T; Rosenzweig, Holly L (2012) Spondyloarthritis: the eyes have it: uveitis in patients with spondyloarthritis. Nat Rev Rheumatol 8:249-50|
|Kezic, Jelena M; Davey, Michael P; Glant, Tibor T et al. (2012) Interferon-Î³ regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondylarthritis. Arthritis Rheum 64:762-71|
|Planck, Stephen R; Woods, April; Clowers, Jenna S et al. (2012) Impact of IL-1 signalling on experimental uveitis and arthritis. Ann Rheum Dis 71:753-60|
|Rosenzweig, Holly L; Planck, Stephen R; Rosenbaum, James T (2011) NLRs in immune privileged sites. Curr Opin Pharmacol 11:423-8|
|Rosenzweig, Holly L; Clowers, Jenna S; Nunez, Gabriel et al. (2011) Dectin-1 and NOD2 mediate cathepsin activation in zymosan-induced arthritis in mice. Inflamm Res 60:705-14|
Showing the most recent 10 out of 14 publications